Skip to content

Spasmodic Dysphonia Interviews

The Socioeconomic Impact of Spasmodic Dysphonia Patients and the Role of Botulinum Toxin

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06561334
Enrollment
20
Registered
2024-08-20
Start date
2024-08-20
Completion date
2025-09-30
Last updated
2025-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life, Spasmodic Dysphonia

Keywords

Qualitative study, Interviews, Quality of life, Spasmodic Dysphonia, Botulinum toxin, Laryngology, Voice disorder

Brief summary

Previous research has shown that patients with voice disorders often have a lower quality of life and struggle with employment. Spasmodic Dysphonia (SD) is a voice disorder that causes abrupt and uncontrollable spasms of the voice box, often resulting in the person having lifelong changes in their voice and speech pattern. The current mainstay of treatment is injecting botulinum toxin (BT) injections into the vocal cord to ease the spasms. The same research team conducted a pilot study in April 2021 on patients with SD. The pilot study used questionnaires and short interviews to understand the livelihood of 10 SD patients. It displayed that SD may impact patients' quality of life. The investigators now aim to run an official research project, ethically approved, to explore the following questions further: 1. Does SD impact the socio-economic lives of its patients? If so, how? 2. What role does BT play in the socio-economic livelihood of SD patients? To answer these questions, the investigators aim to interview 20 patients with Spasmodic Dysphonia.

Interventions

Botulinum toxin injection to ease spasms of vocal cord

Sponsors

Manchester University NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults diagnosed with Spasmodic Dysphonia who have received at least one botulinum toxin injection.

Exclusion criteria

* Below 18 years of age; additional laryngeal condition(s) severely affecting voice.

Design outcomes

Primary

MeasureTime frameDescription
Does Spasmodic Dysphonia impact the socio-economic lives of its patients? If so, how?Through study completion, which is expected to be a yearOutcome will be measured through qualitative analysis of participant answers regarding how the target condition, spasmodic dysphonia, affects the social and economic aspects of their livelihood.

Secondary

MeasureTime frameDescription
What role do botulinum toxin injections play in the socio-economic livelihood of Spasmodic Dysphonia patients?Through study completion, which is expected to be a yearOutcome will be measured through qualitative analysis of participant answers regarding how receiving Botulinum toxin injections may improve their livelihood.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026